Altamira Therapeutics Ltd. (CYTO)
USD 0.3
(0.0%)
USD 0.3
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | 305.61 Thousand | 63.88 Thousand | 174.47 Thousand | -56 Thousand | 1.26 Million |
| Cost of Revenue | - | 1.44 Million | 2.24 Million | - | - | - |
| Gross Profit | - | -1.13 Million | -2.17 Million | 174.47 Thousand | -56 Thousand | 1.26 Million |
| Operating Expenses | 6.53 Million | 24.99 Million | 14.92 Million | 5.45 Million | 7.25 Million | 10.95 Million |
| Selling, General and Administrative Expenses | 3.12 Million | 5.9 Million | 6.39 Million | 2.59 Million | 3.93 Million | 4.26 Million |
| Research and Development Expenses | 3.03 Million | 19.67 Million | 8.93 Million | 2.86 Million | 3.32 Million | 6.68 Million |
| Other Expenses | - | -586.73 Thousand | -409.92 Thousand | - | - | 215.72 Thousand |
| Cost and Expenses | 6.53 Million | 26.43 Million | 17.16 Million | 5.45 Million | 7.25 Million | 10.95 Million |
| Operating Income | -5.91 Million | -26.13 Million | -17.09 Million | -5.28 Million | -7.25 Million | -10.95 Million |
| Interest Expense | - | 911.86 Thousand | 189.69 Thousand | 135.15 Thousand | 28.62 Thousand | 1.07 Million |
| Income Tax Expense | - | -10.32 Thousand | 21.62 Thousand | -21.28 Thousand | -193.83 Thousand | 162.17 Thousand |
| Earnings before Tax | -7.27 Million | -26.53 Million | -17.36 Million | -8.22 Million | -6.82 Million | -11.33 Million |
| Net Income | -7.27 Million | -26.52 Million | -17.39 Million | -8.2 Million | -6.63 Million | -11.49 Million |
| Earnings Per Share Basic | -14.81 | -582.58 | -525.13 | -545.41 | -455.96 | -2892.03 |
| Earnings Per Share Diluted | -14.80 | -582.58 | -525.13 | -545.41 | -455.96 | -2892.03 |
| Weighted Average Shares Outstanding | 491 Thousand | 45.53 Thousand | 33.11 Thousand | 15.03 Thousand | 14.54 Thousand | 3975.20 |
| Weighted Average Shares Outstanding (Diluted) | 491.25 Thousand | 45.53 Thousand | 33.11 Thousand | 15.03 Thousand | 14.54 Thousand | 3975.20 |
| Gross Margin | - | -3.72 | -34.07 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | - | -85.12 | -266.43 | -30.28 | 129.31 | -8.65 |
| Profit Margin | - | -86.80 | -272.22 | -47.00 | 118.43 | -9.08 |
| EBITDA | -1.35 Million | -17.63 Million | -6.71 Million | -5.26 Million | -7.24 Million | -10.95 Million |
| Earnings Before Tax Margin | - | -85.51 | -267.68 | -30.28 | 129.63 | -8.65 |
| Breakdown | 2023 FY | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | 52.73 Thousand | 52.73 Thousand | 305.61 Thousand | - | -458.69 Thousand |
| Cost of Revenue | - | 106.09 Thousand | 106.09 Thousand | 1.44 Million | - | 125.81 Thousand |
| Gross Profit | - | -53.35 Thousand | -53.35 Thousand | -1.13 Million | - | -584.5 Thousand |
| Operating Expenses | 6.53 Million | 2.38 Million | 2.38 Million | 24.99 Million | 635.58 Thousand | 8.74 Million |
| Selling, General and Administrative Expenses | - | 1.16 Million | 1.16 Million | - | 1.71 Million | 907.91 Thousand |
| Research and Development Expenses | - | 1.13 Million | 1.13 Million | - | 3 Million | 8.05 Million |
| Other Expenses | - | - | - | -586.73 Thousand | - | - |
| Cost and Expenses | 6.53 Million | 2.49 Million | 2.49 Million | 26.43 Million | 635.58 Thousand | 8.86 Million |
| Operating Income | -5.91 Million | -2.29 Million | -2.29 Million | -26.13 Million | 5.92 Million | -3.12 Million |
| Interest Expense | - | 584.37 Thousand | - | 911.86 Thousand | - | - |
| Income Tax Expense | -1.35 Million | 5298.00 | 5298.00 | -10.32 Thousand | 20.28 Thousand | 17.87 Thousand |
| Earnings before Tax | -7.27 Million | -2.7 Million | -2.7 Million | -26.53 Million | -781.79 Thousand | -9.59 Million |
| Net Income | -7.27 Million | -2.71 Million | -2.71 Million | -26.52 Million | -802.07 Thousand | -9.61 Million |
| Earnings Per Share Basic | - | -12.91 | -12.97 | - | -2.89 | -199.86 |
| Earnings Per Share Diluted | - | -12.91 | -12.91 | - | -2.89 | -2123.05 |
| Weighted Average Shares Outstanding | 491 Thousand | 209.95 Thousand | 209 Thousand | 45.53 Thousand | 277.08 Thousand | 48.08 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 491.25 Thousand | 209.95 Thousand | 209.95 Thousand | 45.53 Thousand | 277.08 Thousand | 4527.00 |
| Gross Margin | - | -1.01 | -1.01 | -3.72 | - | 1.27 |
| EBIT Margin | - | -7.81 | -7.81 | - | - | 6.81 |
| Profit Margin | - | -51.40 | -51.40 | -86.80 | - | 20.95 |
| EBITDA | - | -412.05 Thousand | -412.05 Thousand | - | 5.97 Million | -3.12 Million |
| Earnings Before Tax Margin | - | -43.48 | -43.48 | -85.51 | - | 6.81 |
NXM
VZLA
7277
BRU
LEG
UOS